Go to the profile of Sibel Konyalıoğlu

Sibel Konyalıoğlu

Prof. Dr., Ege University Pharmacy Faculty
  • Türkiye

Research Interest

Animal Model Apoptosis Cancer Cell Cycle Cell Migration Cell Proliferation Cell Signalling Chemical Biology Drug Design Evolution Gene Therapy Glycobiology Metabolomics Molecular Medicine Protein Expression Protein Structure/Modifications Proteomics Receptors

FEBS Constituent Society

Türkiye (TBS)

Other Expertise/Interests

Journal publishing Postgraduate training Scientific communication

Followed by

Go to the profile of Subham Preetam

Subham Preetam

Early Stage Researcher (R1), The University of Melbourne

Cookie Settings

We and selected partners, use cookies or similar technologies as specified in the cookie policy and privacy policy.

You can consent to the use of such technologies by closing this notice.

Cookie Control

Customise your preferences for any tracking technology

The following allows you to customize your consent preferences for any tracking technology used to help us achieve the features and activities described below. To learn more about how these trackers help us and how they work, refer to the cookie policy. You may review and change your preferences at any time.

Cookie policy Privacy policy
Always active, cannot be turned off
More information

These trackers are used for activities that are strictly necessary to operate or deliver the service you requested from us and, therefore, do not require you to consent.

More information

These trackers help us to deliver personalized marketing content and to operate, serve and track ads.

More information

These trackers help us to deliver personalized marketing content to you based on your behaviour and to operate, serve and track social advertising.

More information

These trackers help us to measure traffic and analyze your behaviour with the goal of improving our service.

More information

These trackers help us to provide a personalized user experience by improving the quality of your preference management options, and by enabling the interaction with external networks and platforms.